Effectiveness of an Active and Continuous Surveillance Program for Intensive Care Units Infections Based on the EPIC III (Extended Prevalence of Infection in Intensive Care) Approach.
antimicrobial stewardship
bacterial
drug resistance
infection control
infections
intensive care unit
point prevalence study
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
28 Apr 2022
28 Apr 2022
Historique:
received:
17
03
2022
revised:
08
04
2022
accepted:
27
04
2022
entrez:
14
5
2022
pubmed:
15
5
2022
medline:
15
5
2022
Statut:
epublish
Résumé
We evaluated the effectiveness of the Extended Prevalence of Infection in Intensive Care (EPIC) III data collection protocol as an active surveillance tool in the eight Intensive Care Units (ICUs) of the Intensive and Critical Care Department of the University Hospital of Turin. A total of 435 patients were included in a six-day study over 72 ICU beds. 42% had at least one infection: 69% at one site, 26% at two sites and 5% at three or more sites. ICU-acquired infections were the most common (64%), followed by hospital-associated infections (22%) and community-acquired (20%), considering that each patient may have developed more than one infection type. 72% of patients were receiving at least one antibiotic: 48% for prophylaxis and 52% for treatment. Mortality, the length of ICU and hospital stays were 13%, 14 and 29 days, respectively, being all estimated to be significantly different in patients without and with infection (8% vs. 20%; 4 vs. 20 and 11 vs. 50 (p < 0.001). Our data confirm a high prevalence of infections, sepsis and the use of antimicrobials. The repeated punctual prevalence survey seems an effective method to carry out the surveillance of infections and the use of antimicrobials in the ICU. The use of the European Centre for Disease Prevention and Control (ECDC) definitions and the EPIC III protocol seems strategic to allow comparisons with national and international contexts.
Identifiants
pubmed: 35566606
pii: jcm11092482
doi: 10.3390/jcm11092482
pmc: PMC9101920
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
JAMA. 1995 Aug 23-30;274(8):639-44
pubmed: 7637145
Ann Ig. 2018 Sep-Oct;30(5 Supple 2):15-21
pubmed: 30374508
Turk J Anaesthesiol Reanim. 2016 Dec;44(6):279-282
pubmed: 28058136
N Engl J Med. 2017 Aug 3;377(5):414-417
pubmed: 28658587
Intensive Care Med. 2018 Apr;44(4):499-501
pubmed: 29500700
Infect Drug Resist. 2021 Nov 27;14:4983-4991
pubmed: 34866918
Minerva Anestesiol. 2019 Jan;85(1):71-82
pubmed: 29991221
BMC Infect Dis. 2020 Jan 23;20(1):75
pubmed: 31973704
JAMA. 2020 Apr 21;323(15):1478-1487
pubmed: 32207816
Ann Ig. 2019 Sep-Oct;31(5):399-413
pubmed: 31304521
Intensive Care Med. 2019 Feb;45(2):172-189
pubmed: 30659311
Intensive Care Med. 2016 Dec;42(12):1980-1989
pubmed: 27686355
JAMA. 2016 Feb 23;315(8):801-10
pubmed: 26903338
Rev Bras Ter Intensiva. 2012 Jun;24(2):143-50
pubmed: 23917761
Crit Care. 2021 Oct 15;25(1):360
pubmed: 34654462
Intensive Care Med. 2018 Dec;44(12):2216-2218
pubmed: 29797028
PLoS One. 2014 Sep 16;9(9):e107181
pubmed: 25226033
Turk J Anaesthesiol Reanim. 2016 Dec;44(6):283-284
pubmed: 28058137
Clin Microbiol Infect. 2012 Mar;18(3):268-81
pubmed: 21793988
Swiss Med Wkly. 2018 Apr 26;148:w14617
pubmed: 29698542
Infect Control Hosp Epidemiol. 2021 Oct 18;:1-8
pubmed: 34657648
JAMA. 2020 Apr 21;323(15):1451-1452
pubmed: 32207775
JAMA. 2009 Dec 2;302(21):2323-9
pubmed: 19952319
Intensive Care Med. 2020 Aug;46(8):1536-1551
pubmed: 32591853
Crit Care. 2018 Apr 16;22(1):93
pubmed: 29656714
Lancet. 2020 Jan 18;395(10219):200-211
pubmed: 31954465
Infect Control Hosp Epidemiol. 2018 Nov;39(11):1277-1295
pubmed: 30234463
Lancet Infect Dis. 2018 Mar;18(3):318-327
pubmed: 29276051
Euro Surveill. 2018 Nov;23(46):
pubmed: 30458912
Euro Surveill. 2016 Nov 17;21(46):
pubmed: 27918266
Lancet Infect Dis. 2019 Jan;19(1):56-66
pubmed: 30409683
Minerva Anestesiol. 2020 Dec;86(12):1305-1320
pubmed: 33337119
Intensive Care Med. 2020 Feb;46(2):245-265
pubmed: 31781835
Am J Respir Crit Care Med. 2016 Feb 1;193(3):259-72
pubmed: 26414292
Open Forum Infect Dis. 2018 Nov 19;5(12):ofy313
pubmed: 30555852